Existing approaches to testing potential treatments through drug screening do not take account of the fact that the genetic errors that cause kidney diseases vary from patient to patient
Researchers discovered that some pancreatic tumors produce more of a molecule called 'perlecan' to remodel the environment around them, helping cancer cells spread more easily to other parts of the body